Katharina Boroviak

Katharina Boroviak has a diverse background of experience in the scientific field. Katharina is currently employed at Adrestia Therapeutics, where they hold the position of Principal Scientist. Prior to this, they worked as a Senior Scientist at the same company from April 2021 to December 2021.

Before joining Adrestia Therapeutics, Boroviak worked at bit.bio as a Senior Scientist from September 2020 to February 2021. Katharina also held positions at the Wellcome Sanger Institute, starting as a Staff Scientist in November 2013 and progressing to the role of Senior Staff Scientist from August 2018 to September 2020.

Boroviak's earliest work experience was at the Wellcome Trust - Medical Research Council Cambridge Stem Cell Institute, where they served as the Facility Manager from November 2010 to October 2013.

Overall, Katharina Boroviak has had a successful career in the scientific field, with a focus on senior roles and research in various organizations.

Katharina Boroviak obtained a Master's degree in Molecular Biology from the University of Vienna between 2003 and 2007. Katharina later pursued a Doctor of Philosophy (PhD) in Biomedical Sciences, General at The University of Sheffield from 2007 to 2010.